A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
Yang, Eddy S., Deutsch, Eric, Mehmet, Altan, Fayette, Jerome, TAO, Yungan, Nabell, Lisle, Spencer, Sharon A., Wang, Xuejing A., Spoljoric, Elizabeth A., Zhang, Wei, Hynes, Scott M., Decker, Rodney L., Lin, Aimee K. Bence, William, William N.
Published in Radiotherapy and oncology (01.04.2021)
Published in Radiotherapy and oncology (01.04.2021)
Get full text
Journal Article
Microsampling in pediatric studies: pharmacokinetic sampling for baricitinib (Olumiant™) in global pediatric studies
Wickremsinhe, Enaksha R, Decker, Rodney L, Lee, Lisa B, Lelle, Erica, Carlton, Lena A, Keller, Stuart Y, Prakash, Apurva
Published in Bioanalysis (01.06.2023)
Published in Bioanalysis (01.06.2023)
Get full text
Journal Article
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis
Decker, Rodney L., Steven Ernest, C., Radtke, David B., Wang, Rona, Araújo, Joana, Keller, Stuart Y., Zhang, Xin
Published in CPT: pharmacometrics and systems pharmacology (01.06.2024)
Published in CPT: pharmacometrics and systems pharmacology (01.06.2024)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of LY2599666, a PEG-Linked Antigen Binding Fragment that Targets Soluble Monomer Amyloid-β
Li, Li, Zhen, Eugene Y, Decker, Rodney L, Willis, Brian A, Waters, David, Liu, Peng, Hake, Ann Marie, Demattos, Ronald Bradley, Ayan-Oshodi, Mosun
Published in Journal of Alzheimer's disease (01.01.2019)
Published in Journal of Alzheimer's disease (01.01.2019)
Get more information
Journal Article
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma
Villalobos, Victor M., Mo, Gary, Agulnik, Mark, Pollack, Seth M., Rushing, Daniel A., Singh, Arun, Van Tine, Brian A., McNaughton, Rhian, Decker, Rodney L., Zhang, Wei, Shahir, Ashwin, Cronier, Damien M.
Published in Cancer medicine (Malden, MA) (01.02.2020)
Published in Cancer medicine (Malden, MA) (01.02.2020)
Get full text
Journal Article
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study
Kilburn, Lindsay B, Kocak, Mehmet, Decker, Rodney L, Wetmore, Cynthia, Chintagumpala, Murali, Su, Jack, Goldman, Stewart, Banerjee, Anuradha, Gilbertson, Richard, Fouladi, Maryam, Kun, Larry, Boyett, James M, Blaney, Susan M
Published in Neuro-oncology (Charlottesville, Va.) (01.02.2015)
Published in Neuro-oncology (Charlottesville, Va.) (01.02.2015)
Get full text
Journal Article
A phase Ib study of prexasertib, a checkpoint kinase (CHK1) inhibitor, and LY3023414, a dual inhibitor of class I phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) in patients with advanced solid tumors
Hong, David S., Moore, Kathleen N., Bendell, Johanna C., Karp, Daniel D., Wang, Judy Sing-Zan, Ulahannan, Susanna Varkey, Johnson, Melissa Lynne, Aljumaily, Raid, Hynes, Scott, Callies, Sophie, Decker, Rodney, LaBell, Elizabeth, Niland, Michele, Wang, Xuejing Aimee, Bence Lin, Aimee, Patel, Manish R.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients
Hynes, Scott M., Wickremsinhe, Enaksha, Zhang, Wei, Decker, Rodney, Ott, Jennifer, Chandler, Jason, Mitchell, Malcolm
Published in Biopharmaceutics & drug disposition (01.01.2015)
Published in Biopharmaceutics & drug disposition (01.01.2015)
Get full text
Journal Article
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics
Nwankwo, Nwabundo, Zhang, Zhe, Wang, Ting, Collins, Connie, Resta, Lee, Ermisch, Sabine, Day, Jeannette, Decker, Rodney, Kornberg, Lori, Nicol, Steven, Thornton, Donald, Armstrong, Deborah K., Carducci, Michael A.
Published in Investigational new drugs (01.06.2013)
Published in Investigational new drugs (01.06.2013)
Get full text
Journal Article
Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma
Schmidinger, Manuela, Szczylik, Cezary, Sternberg, Cora N, Kania, Marek, Kelly, Claudia Sue, Decker, Rodney, Hamid, Oday, Faelker, Taron, Escudier, Bernard
Published in American journal of clinical oncology (01.10.2012)
Published in American journal of clinical oncology (01.10.2012)
Get more information
Journal Article
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)
Rampling, Roy, Sanson, Marc, Gorlia, Thiery, Lacombe, Denis, Lai, Christina, Gharib, Myriam, Taal, Walter, Stoffregen, Clemens, Decker, Rodney, van den Bent, Martin J
Published in Neuro-oncology (Charlottesville, Va.) (01.03.2012)
Published in Neuro-oncology (Charlottesville, Va.) (01.03.2012)
Get full text
Journal Article
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
Padda, Sukhmani K., Krupitskaya, Yelena, Chhatwani, Laveena, Fisher, George A., Colevas, Alexander D., San Pedro-Salcedo, Melanie, Decker, Rodney, Latz, Jane E., Wakelee, Heather A.
Published in Cancer chemotherapy and pharmacology (01.04.2012)
Published in Cancer chemotherapy and pharmacology (01.04.2012)
Get full text
Journal Article